Filter posts

The BioGENEius Challenge is a Keystone Event at the BIO International Convention

Part One: A Look Back Read part two of Robert’s story The gathering of leaders …

Diversity Critical to Building Rich Bioscience Centers

Whether producing natural gas from coal or creating lifesaving medicines, unique experiences are what often …

BIO IPCC Conference Launches Next Week

BIO’s IPCC Spring Conference is in San Diego next week, March 25-27.  Find this year’s …

GEN’s “Top 10” Session Picks for the 2013 BIO International Convention

As the industry moves forward in 2013, it again faces one of its regular bugaboos—uncertainty. …

Forbes 30 Under 30: Rising Biotech Stars at the 2013 BIO International Convention

For the second year in a row, Forbes magazine published a list of the most …

Call for Nominations: BIO International Convention's Buzz of BIO Contest

The BIO International Convention is all about raising your profile. Make connections, get your story …

Show Me the Money: Reimbursement in an ACA World

A panel at the BIO CEO & Investor Conference focused on reimbursement discussed value from a …

Word on the Street – Biotech Stocks Only Have Room to Go Up

The Opening Lunch Plenary at this year’s BIO CEO & Investor Conference was a lively …

Celgene CEO on New Multiple Myeloma Drug Approvals

Following on the heels of two big announcements in February, Celgene CEO Robert Hugin (one …

Simpson Bowles Keynote to Address Debt, Taxes, Government Services and Politics

I was recently asked what the single biggest threat to the biotechnology industry is today.  …